Malaga Cove Capital, LLC Amgen Inc Transaction History

Malaga Cove Capital, LLC

$233 Million
Q1 2024

A detailed history of Malaga Cove Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Malaga Cove Capital, LLC holds 15,304 shares of AMGN stock, worth $4.76 Million. This represents 1.87% of its overall portfolio holdings.

Number of Shares

15,304

Previous 15,343 0.25%

Holding current value

$4.76 Million

Previous $4.42 Million 1.54%

% of portfolio

1.87%

Previous 1.94%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $10,485 - $12,657	-39 Reduced 0.25%	15,304 $4.35 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $8,182 - $9,230	-32 Reduced 0.21%	15,343 $4.42 Million
Q3 2023 Oct 31, 2023	SELL	$218.65 - $271.46 $18,147 - $22,531	-83 Reduced 0.54%	15,375 $4.13 Million
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $32,783 - $38,765	-153 Reduced 0.98%	15,458 $3.43 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $4,290 - $5,228	-19 Reduced 0.12%	15,611 $3.77 Million

Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $1.15 Million - $1.47 Million	-5,040 Reduced 24.38%	15,630 $4.11 Million
Q3 2022 Nov 07, 2022	SELL	$224.46 - $253.15 $23,568 - $26,580	-105 Reduced 0.51%	20,670 $4.66 Million
Q2 2022 Aug 02, 2022	SELL	$230.71 - $256.74 $1,845 - $2,053	-8 Reduced 0.04%	20,775 $5.05 Million
Q1 2022 Apr 28, 2022	SELL	$219.27 - $242.57 $24,777 - $27,410	-113 Reduced 0.54%	20,783 $5.03 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $28,439 - $32,546	-143 Reduced 0.68%	20,896 $4.7 Million
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $16,769 - $19,647	-79 Reduced 0.37%	21,039 $4.47 Million
Q2 2021 Jul 27, 2021	BUY	$233.58 - $259.14 $1,635 - $1,813	7 Added 0.03%	21,118 $5.15 Million
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $401,213 - $467,548	-1,808 Reduced 7.89%	21,111 $5.25 Million
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $27,696 - $32,981	-128 Reduced 0.56%	22,919 $5.22 Million
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $7,274 - $8,089	31 Added 0.13%	23,047 $5.86 Million
Q2 2020 Jul 29, 2020	SELL	$197.81 - $242.74 $174,666 - $214,339	-883 Reduced 3.69%	23,016 $5.43 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $275,364 - $365,208	-1,511 Reduced 5.95%	23,899 $4.88 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $82,495 - $106,035	-436 Reduced 1.69%	25,410 $6.13 Million
Q3 2019 Oct 31, 2019	SELL	$174.11 - $208.62 $123,618 - $148,120	-710 Reduced 2.67%	25,846 $5 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $72,681 - $85,198	-436 Reduced 1.62%	26,556 $4.89 Million
Q1 2019 Apr 11, 2019	SELL	$180.87 - $203.88 $137,461 - $154,948	-760 Reduced 2.74%	26,992 $5.13 Million
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $132,729 - $154,938	-744 Reduced 2.61%	27,752 $5.41 Million
Q3 2018 Oct 15, 2018	SELL	$185.29 - $208.89 $118,770 - $133,898	-641 Reduced 2.2%	28,496 $5.94 Million
Q2 2018 Aug 01, 2018	SELL	$166.05 - $186.51 $174,186 - $195,648	-1,049 Reduced 3.48%	29,137 $5.38 Million
Q1 2018 Apr 16, 2018	SELL	$169.43 - $198.0 $36,766 - $42,966	-217 Reduced 0.71%	30,186 $5.15 Million
Q4 2017 Jan 31, 2018	SELL	$168.79 - $188.59 $50,974 - $56,954	-302 Reduced 0.98%	30,403 $5.29 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $5.14 Million - $5.86 Million	30,705	30,705 $5.71 Million

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Malaga Cove Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Malaga Cove Capital, LLC with notifications on news.

Account

Malaga Cove Capital, LLC Amgen Inc Transaction History